Cohance Lifesciences

About, Contact Details

PRESENTATION(s)

Company Brochure 2023, GMP Certificate 2024, Antibody-Drug Conjugate Brochure 2024, FDF Product List 2024, API Product List 2024, Intermediate Product List 2024, Pellet Product List 2024

VIDEO(s)

No Video

DIGITAL CONTENT

23 News

23 News

APIs // Active Pharmaceutical Ingredients

95 APIs, 24 USDMF, 27 CEP/COS, 2 JDMF, 20 EU WC, 17 KDMF, 44 NDC API, 81 Listed APIs

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

DOSSIERs // Finished Dosage Forms

133 Dossiers, 133 Listed Dossiers

KEY PRODUCTS

Exatecan, Irinotecan Hydrochloride, Lenalidomide, Methotrexate, S-trione, SN38, Topotecan Hydrochloride

INTERMEDIATES

36 Listed Products

36 Listed Products

SERVICES

All Services, API Manufacturing, API & Drug Product Development

All Services
API Manufacturing
API & Drug Product Development
- 6 API Development

KEY SERVICES

Antibody Drug Conjugates (ADCs), Custom Development & Manufacturing for ADCs

INSPECTIONS & REGISTRATIONS

16 FDA, 5 EDQM, 1 WHO-GMP, 1 GDUFA

List of Drug Master Files (JDMF) of Active Pharmaceutical Ingredients (APIs) submitted by Cohance Lifesciences to the Review Authority in Japan (PMDA). Original Data : PMDA